![Darlene Noci](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 6 M $ al 31/05/2026
Darlene Noci is the founder of Noci Strategic Consulting LLC, founded in 2018.
The current job is Chief Development Officer at Nuvalent, Inc., starting in 2022, with employment at Nuvalent beginning in 2021.
Former jobs include Head-Regulatory Affairs at AVEO Pharmaceuticals, Inc., VP-Regulatory Affairs & Quality Assurance at X4 Pharmaceuticals, Inc. from 2016 to 2018, and Principal at EMD Serono, Inc. from 2014 to 2016.
Education includes graduate studies at Harvard University and undergraduate studies at Adelphi University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NUVALENT, INC. CLASS A 0,09 % | 28/05/2026 | 58.117 ( 0,09 % ) | 6 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NUVALENT, INC. | Corporate Officer/Principal | 20/07/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Consejero General | 01/05/2018 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01/01/2016 |
Noci Strategic Consulting LLC | Fundador | - |
| AVEO PHARMACEUTICALS, INC. | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adelphi University
 Adelphi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Noci Strategic Consulting LLC |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
